Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial

Blood

Volumn 94, Issue 5, 1999, Pages 1550-1554

  Kinney, Thomas R ^a   Helms, Ronald W ^b   O'Branski, Erin E ^b   Ohene Frempong, Kwaku ^b   Wang, Winfred ^b   Daeschner, Charles ^b   Vichinsky, Elliott ^b   Redding Lallinger, Rupa ^b   Gee, Beatrice ^b   Platt, Orah S ^b   Ware, Russell E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ARTICLE; BLOOD TOXICITY; CHILD; CHILD GROWTH; CLINICAL TRIAL; CYTOPENIA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MULTICENTER STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HUMANS; HYDROXYUREA; MALE; TREATMENT OUTCOME;

EID: 13044277572     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR: Effect of hydroxyurea on frequency of painful crisis in sickle cell anemia. N Engl J Med 332:1317, 1995
2. Scott JP, Hillery CA, Brown ER, Misiewica V, Labotka RJ: Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 128:820, 1996
3. de Montalembert M, Belloy M, Bernaudin F, Gourard F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R: Three year follow-up of hydroxyurea treatment in children with sickle cell disease. The French Study Group on Sickle Cell Disease. Am J Pediatr Hematol Oncol 19:313, 1997
4. Jayabose S, Tugal O, Sandoval C, Patel P, Puder D, Lin D, Visintainer P: Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 129:559, 1996
5. Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E: Hydroxyurea for the treatment of severe sickle cell anemia: A pediatric clinical trial. Blood 88:1960, 1996
6. Olivieri NF, Vichinsky EP: Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy. Am J Pediatr Hematol Oncol 20:26, 1998
7. Weinfield A, Swolin B, Westin J: Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications. Eur J Haematol 52:134, 1994
8. Wiger R, Hongslo JK, Evenson DP, De Angelis P, Schwarze PE, Holme JA: Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory mice. Reprod Toxicol 9:21, 1995
9. Kim HC, Adachi K, Schwartz E: Separation of hemoglobins, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams' Hematology (ed 5). New York, NY, McGraw Hill, 1994, p L37
10. Horiuchi K, Fynn-Thompson F, Ohene-Frempong K: Quantitative analysis of the degree of irreversible deformation of F cells and non-F cells and its relationship to cell density in sickle cell disease. Exp Hematol 22:1058, 1994
11. Horiuchi K, Osterhout ML, Bekoe N, Kamma H, Bekoe NA, Hirokawa KJ: Estimation of fetal hemoglobin levels in individual red cells by fluorescence image cytometry. Cytometry 20:261, 1995
12. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell disease. Blood 79:2555, 1992